None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 19 years or older who agree to participate in the clinical trial and have signed the informed consent form. 2. Sites in the posterior maxilla where more than 3 months have passed since tooth extraction. 3. Patients requiring maxillary sinus augmentation, in whom preoperative computed tomography shows 4–8 mm of vertical bone height at the edentulous site in the posterior maxilla, making them suitable candidates for a crestal approach to place implants of 8–10 mm in length. 4. Patients with no pathological findings in the maxillary sinus area.
Exclusion criteria
Exclusion criteria: 1.Patients with uncontrolled metabolic diseases (e.g., uncontrolled diabetes). 2.Individuals with a history of taking medications that may affect bone metabolism (e.g., bisphosphonates or denosumab) within the past 3 months. 3.Patients with uncontrolled gingivitis, periodontitis, or dental caries. 4.Patients with a history of tumor resection at the planned surgical site. 5.Individuals who have undergone chemotherapy or radiation therapy to the craniofacial region. 6.Heavy smokers consuming more than one pack (20 cigarettes) per day. 7.Pregnant or breastfeeding patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Three-dimensional evaluation of volumetric changes in the grafted maxillary sinus area over time | — |
Secondary
| Measure | Time frame |
|---|---|
| Two-dimensional evaluation of height changes in the grafted maxillary sinus area over time.;Evaluation of initial stability and osseointegration of the implanted implants.;Evaluation of alveolar ridge volume changes at the implant placement site.;Evaluation of patient and clinician satisfaction survey results.;Measurement of surgery duration. | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Dental Hospital